Skip to content

Sirona Pharma

Active Private limited companyfounded 2021active for 5 yearsLéon de Lantsheerestraat 26, 1040 EtterbeekKBO/BCE: BE 0762.777.019

Lifetime

5 annual accounts with figures on one time axis
peak of €19,823 in 2025
€19,823▲ 18×
lowest -€17,905 in 2023
€19,208▲ €19,344
peak of €10,143 in 2025
€10,143▲ €19,208
€127,883▼ 14.9%
Board1 name since 2021
1 director
Documentsfilings and deeds
01-04-2026121 days before the deadline
2025micro format
Gross margin from €1,104 to €19,823Profit of €19,208, after a lossEquity from -€9,065 to €10,143Cash from €6,971 to €4,508

Key points

from the 2025 annual accounts

Turnover

≈ €210,000 estimated

The micro format states no turnover.

Debts

€127,883 93% of the balance sheet
Suppliers 94%Taxes and wages 1%Other 5%

Of this, €121,883 falls due within a year.

Filings

5 annual accounts 1 late
AprilJune31 JulyOctober20222024

The 2023 accounts came 2 days late. The other four were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Sirona Pharma has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Sirona Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
  • 50 sharesdeed of 03-02-2021
  • 50 sharesdeed of 03-02-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0762777019
Incorporation Founding capital of €10,000, 100 shares · Founders: (comparant) and (comparant) · Appointment: (director) · published on 03-02-2021 · Gazette deed
First establishment Léon de Lantsheerestraat 26, Etterbeek
All 11 events

Comparable companies

same main activity, similar in size and age
Company
Sirona Pharma Etterbeek - - 7.3% -
PHARMACIE CAPUCINE Brussels - - 82.1% -
Beisol Pharma Lubbeek Lubbeek €30,000 11.2% 12.7% -
ANTOINE DERBAUD Ham-sur-Heure-Nalinnes €67,557 32.0% 68.1% -
Pharmacie du Bien-être Brussels - - 51.5% -
BVV Affligem - - 99.1% -
F-88 Bree - - 13.2% -

These companies have the same main activity as Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €96,500 and €203,000, founded between 2018 and 2022.

Official details

Source: KBO
Status
Active since 01-02-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.313.509.1881040 Etterbeek, since 01-02-2021
Financial year end
31 December
Peppol
Reachable since 18-12-2025
Company details

Annual accounts 2025

€138,027▼ 2.3%
Filing
Filed on 01-04-2026, 121 days before the end of the filing period
Financials

Insights on Sirona Pharma

Pharma files the micro format. That format states no turnover. The gross margin rose from -€6,298 in 2021 to €19,823 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Sirona Pharma

What is the company number of Sirona Pharma?
The company number of Pharma is 0762.777.019. The VAT number is the same number with BE in front: BE 0762.777.019.
Where is Sirona Pharma based?
The registered office is at Léon de Lantsheerestraat 26, 1040 Etterbeek.Company details
What does Sirona Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Sirona Pharma?
Pharma is a private limited company (BV).
When was Sirona Pharma founded?
Pharma was founded on 01-02-2021.
Is Sirona Pharma still active?
Yes, Pharma is an active enterprise in the KBO register.
What is the turnover of Sirona Pharma?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €19,823 and 138 comparable companies (NACE 477). It probably lies between €78,000 and €450,000. It is a rough estimate.Financials
Is Sirona Pharma profitable?
In financial year 2025, Pharma made a profit of €19,208.
Where can I find the annual accounts of Sirona Pharma?
Pharma filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Sirona Pharma due?
Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.